Pulmonary embolism (PE) is a serious and potentially fatal condition, and with its high incidence and mortality rate, it ranks as the third most common cardiovascular syndrome worldwide [1]. With the advancement in imaging technology, including improved image quality, the sensitivity of PE detection has increased [2]. CT pulmonary angiography (CTPA) is currently the first-line modality for diagnosing PE due to its excellent accuracy and low rate of inconclusive results [3,4]. Now, clinicians are…